Sequential Induction of Pro- and Anti-inflammatory Prostaglandins and Peroxisome Proliferators-activated Receptor-gamma During Normal Wound Healing: a Time Course Study

Overview

Journal Prostaglandins Leukot Essent Fatty Acids

Specialty Endocrinology

Date 2007 Jan 24

PMID 17239574

Citations 31

Authors

Mohit Kapoor

Fumiaki Kojima

Lihua Yang

Leslie J Crofford

Affiliations

Soon will be listed here.

Abstract

Lipid mediators generated from metabolism of arachidonic acid play a crucial role in the initiating and resolution of acute inflammation by shifting from pro-inflammatory prostaglandin (PG) E2 to anti-inflammatory PGD2 and its metabolites. The changes in PG levels over time during the normal wound-repair process have not, however, been reported. We determined the temporal expression of PG and their biosynthetic enzymes using the full thickness incisional model of normal wound healing in mice. We demonstrate that during normal wound repair, there is a shift in the metabolism of arachidonate from PGE2 during the acute inflammatory phase to PGD2 during the repair phase. This shift is mediated by temporal changes in the expression of cyclooxygenases (COX) and microsomal PGES (mPGES)-1. Inducible COX (COX-2) expression is sustained throughout the initiation and repair process, but mPGES-1 is increased only during the acute inflammatory phase and its disappearance coincides with increased PGD2. PGD2 and its degradation products are known to mediate their anti-inflammatory effects by binding to peroxisome proliferators-activated receptor gamma (PPARgamma). In this study, we show that PPARgamma is upregulated during the resolution phase of wound repair concomitant with the shift to PGD2, and may be responsible for initiating endogenous mechanism resulting in healing/resolution.

Citing Articles

Prolonged Cold Exposure Negatively Impacts Atlantic Salmon () Liver Metabolism and Function.

Rojas I, Caballero-Solares A, Vadboncoeur E, Sandrelli R, Hall J, Clow K Biology (Basel). 2024; 13(7).

PMID: 39056688 PMC: 11273521. DOI: 10.3390/biology13070494.

Vegetable omega-3 and omega-6 fatty acids differentially modulate the antiviral and antibacterial immune responses of Atlantic salmon.

Caballero-Solares A, Eslamloo K, Hall J, Katan T, Emam M, Xue X Sci Rep. 2024; 14(1):10947.

PMID: 38740811 PMC: 11091188. DOI: 10.1038/s41598-024-61144-w.

Effect of the Combined Compound Probiotics with Glycyrrhinic Acid on Alleviating Cytotoxicity of IPEC-J2 Cells Induced by Multi-Mycotoxins.

Wang L, Wang X, Chang J, Wang P, Liu C, Yuan L Toxins (Basel). 2022; 14(10).

PMID: 36287939 PMC: 9612255. DOI: 10.3390/toxins14100670.

How Aconiti Radix Cocta can Treat Gouty Arthritis Based on Systematic Pharmacology and UPLC-QTOF-MS/MS.

Ye X, Wu J, Zhang D, Lan Z, Yang S, Zhu J Front Pharmacol. 2021; 12:618844.

PMID: 33995019 PMC: 8121251. DOI: 10.3389/fphar.2021.618844.

Effect of photobiomodulation (670 nm) associated with vitamin A on the inflammatory phase of wound healing.

Otterco A, Brassolatti P, Andrade A, Avo L, Bossini P, Parizotto N Lasers Med Sci. 2018; 33(9):1867-1874.

PMID: 29790013 DOI: 10.1007/s10103-018-2535-4.

References

Kojima F, Naraba H, Miyamoto S, Beppu M, Aoki H, Kawai S . Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis. Arthritis Res Ther. 2004; 6(4):R355-65. PMC: 464891. DOI: 10.1186/ar1195. View

Kapoor M, Howard R, Hall I, Appleton I . Effects of epicatechin gallate on wound healing and scar formation in a full thickness incisional wound healing model in rats. Am J Pathol. 2004; 165(1):299-307. PMC: 1618547. DOI: 10.1016/S0002-9440(10)63297-X. View

Urade Y, Fujimoto N, HAYAISHI O . Purification and characterization of rat brain prostaglandin D synthetase. J Biol Chem. 1985; 260(23):12410-5. View

Narumiya S, Fukushima M . Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. J Pharmacol Exp Ther. 1986; 239(2):500-5. View

Hirata Y, Hayashi H, Ito S, Kikawa Y, Ishibashi M, Sudo M . Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine. J Biol Chem. 1988; 263(32):16619-25. View

Miadonna A, Tedeschi A, BRASCA C, Folco G, Sala A, Murphy R . Mediator release after endobronchial antigen challenge in patients with respiratory allergy. J Allergy Clin Immunol. 1990; 85(5):906-13. DOI: 10.1016/0091-6749(90)90076-g. View

Fukushima M . Biological activities and mechanisms of action of PGJ2 and related compounds: an update. Prostaglandins Leukot Essent Fatty Acids. 1992; 47(1):1-12. DOI: 10.1016/0952-3278(92)90178-l. View

Kliewer S, Lenhard J, Willson T, Patel I, Morris D, Lehmann J . A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell. 1995; 83(5):813-9. DOI: 10.1016/0092-8674(95)90194-9. View

Kanaoka Y, Ago H, Inagaki E, Nanayama T, Miyano M, Kikuno R . Cloning and crystal structure of hematopoietic prostaglandin D synthase. Cell. 1997; 90(6):1085-95. DOI: 10.1016/s0092-8674(00)80374-8. View

10.

Ricote M, Li A, Willson T, Kelly C, Glass C . The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998; 391(6662):79-82. DOI: 10.1038/34178. View

11.

Gilroy D, Colville-Nash P, Willis D, Chivers J, Paul-Clark M, Willoughby D . Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 1999; 5(6):698-701. DOI: 10.1038/9550. View

12.

Jakobsson P, Thoren S, Morgenstern R, Samuelsson B . Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A. 1999; 96(13):7220-5. PMC: 22058. DOI: 10.1073/pnas.96.13.7220. View

13.

Farrajota K, Cheng S, Martel-Pelletier J, Afif H, Pelletier J, Li X . Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. Arthritis Rheum. 2005; 52(1):94-104. DOI: 10.1002/art.20714. View

14.

Sampey A, Monrad S, Crofford L . Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2. Arthritis Res Ther. 2005; 7(3):114-7. PMC: 1174970. DOI: 10.1186/ar1748. View

15.

Kojima F, Kato S, Kawai S . Prostaglandin E synthase in the pathophysiology of arthritis. Fundam Clin Pharmacol. 2005; 19(3):255-61. DOI: 10.1111/j.1472-8206.2005.00316.x. View

16.

Kapoor M, Shaw O, Appleton I . Possible anti-inflammatory role of COX-2-derived prostaglandins: implications for inflammation research. Curr Opin Investig Drugs. 2005; 6(5):461-6. View

17.

Sanchez-Hidalgo M, Martin A, Villegas I, Alarcon de La Lastra C . Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Biochem Pharmacol. 2005; 69(12):1733-44. DOI: 10.1016/j.bcp.2005.03.024. View

18.

Kapoor M, Clarkson A, Sutherland B, Appleton I . The role of antioxidants in models of inflammation: emphasis on L-arginine and arachidonic acid metabolism. Inflammopharmacology. 2005; 12(5-6):505-19. DOI: 10.1163/156856005774382797. View

19.

Srinivasan D, Kapoor M, Kojima F, Crofford L . Growth factor receptors: implications in tumor biology. Curr Opin Investig Drugs. 2005; 6(12):1246-9. View

20.

Kohno S, Endo H, Hashimoto A, Hayashi I, Murakami Y, Kitasato H . Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma. Biomed Pharmacother. 2005; 60(1):18-25. DOI: 10.1016/j.biopha.2005.04.004. View